25.05.2021 /
scienceCLASH podcast funded for a second season
Pentixapharm publishes positive Phase II data on Pentixafor PET diagnostics
OMEICOS Therapeutics Announces Positive Phase 2 Study Outcome Demonstrating OMT-28’s Potential in Primary Mitochondrial Diseases (PMD)
